Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 22;13(7):1195.
doi: 10.3390/v13071195.

Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies

Shiyu Dai  1 , Fei Deng  1   2 , Hualin Wang  1   2 , Yunjia Ning  1   2
Affiliations
Review

Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies

Shiyu Dai et al. Viruses. .

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is a widespread, tick-borne pathogen that causes Crimean-Congo hemorrhagic fever (CCHF) with high morbidity and mortality. CCHFV is transmitted to humans through tick bites or direct contact with patients or infected animals with viremia. Currently, climate change and globalization have increased the transmission risk of this biosafety level (BSL)-4 virus. The treatment options of CCHFV infection remain limited and there is no FDA-approved vaccine or specific antivirals, which urges the identification of potential therapeutic targets and the design of CCHF therapies with greater effort. In this article, we discuss the current progress and some future directions in the development of antiviral strategies against CCHFV.

Keywords: Crimean-Congo hemorrhagic fever virus; antiviral strategies; bunyavirus; tick-borne virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Spengler J.R., Bente D.A., Bray M., Burt F., Hewson R., Korukluoglu G., Mirazimi A., Weber F., Papa A. Second International Conference on Crimean-Congo Hemorrhagic Fever. Antivir. Res. 2018;150:137–147. doi: 10.1016/j.antiviral.2017.11.019. - DOI - PMC - PubMed
    1. Papa A., Tsergouli K., Tsioka K., Mirazimi A. Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions. Front. Cell Infect. Microbiol. 2017;7:213. doi: 10.3389/fcimb.2017.00213. - DOI - PMC - PubMed
    1. Mendoza E.J., Warner B., Safronetz D., Ranadheera C. Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures. Zoonoses Public Health. 2018;65:465–480. doi: 10.1111/zph.12469. - DOI - PMC - PubMed
    1. Haddock E., Feldmann F., Hawman D.W., Zivcec M., Hanley P.W., Saturday G., Scott D.P., Thomas T., Korva M., Avsic-Zupanc T., et al. A cynomolgus macaque model for Crimean-Congo haemorrhagic fever. Nat. Microbiol. 2018;3:556–562. doi: 10.1038/s41564-018-0141-7. - DOI - PMC - PubMed
    1. Ranadheera C., Valcourt E.J., Warner B.M., Poliquin G., Rosenke K., Frost K., Tierney K., Saturday G., Miao J., Westover J.B., et al. Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis. Sci. Rep. 2020;10:12378. doi: 10.1038/s41598-020-69054-3. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances